A
AVITAL
Hello all,
I have a question re design validation. FDA requires that during design validation, product used for the validation should be the "initial production units, lots, or batches, or their equivalents". we manufacture Titanium Implants, and our process usually starts in CNC department to machine the parts, and then there are several surface treatments. my question is, can we machine the parts in R&D workshop, then inspect and release them by QA and then continue the surface treatment in production. Meaning, could those parts meet the term of "their equivalent" quoted before? The rational here is that the machining step of the production process, is mainly about meeting the drawing requirements, and it does not really matter if we met them by using R&D machines or production machines. This can really reduce our time to market, but we have to be in compliance?
thanks you for your attention!
I have a question re design validation. FDA requires that during design validation, product used for the validation should be the "initial production units, lots, or batches, or their equivalents". we manufacture Titanium Implants, and our process usually starts in CNC department to machine the parts, and then there are several surface treatments. my question is, can we machine the parts in R&D workshop, then inspect and release them by QA and then continue the surface treatment in production. Meaning, could those parts meet the term of "their equivalent" quoted before? The rational here is that the machining step of the production process, is mainly about meeting the drawing requirements, and it does not really matter if we met them by using R&D machines or production machines. This can really reduce our time to market, but we have to be in compliance?
thanks you for your attention!